Video Game Study Paves Path For Pivotal FDA Trial To Treat Pediatric ADHD
This article was originally published in The Gray Sheet
Executive Summary
A new video game treatment called Project: EVO being developed by Boston-based Akili Labs has crossed an important milestone with positive pilot study data for treating children with attention deficit hyperactivity disorder. The company is planning to launch a randomized, pivotal study to support FDA approval of a "prescription-strength video game" in the coming months.